AINewsnow

Google DeepMind releases AlphaGenome 2 for cell-type-specific variant predictions

Google DeepMind unveiled AlphaGenome 2, a conditional DNA sequence model that predicts regulatory activity and variant effects per cell type, trained on over 107 million cell profiles and available via API for non-commercial use.

Read the full story at MarkTechPost ↗

Timeline · 3 reports

  1. 2026-11-12 12:09 · The Decoder
    Google Deepmind shifts genomics AI from bulk tissue predictions to single cell type resolution with AlphaGenome 2
  2. 2026-11-11 20:56 · r/machinelearningnews
    Google DeepMind releases AlphaGenome 2, a cell-type-conditioned DNA model (30% vs 16% causal sc-eQTL recall at 90% precision)
  3. 2026-11-11 20:51 · MarkTechPost
    Google DeepMind Releases AlphaGenome 2 for Cell-Type-Specific Variant Effects

More stories

  1. Google DeepMind unveils AlphaGenome 2 to read the entire human genome — Google DeepMind YouTube
  2. Google connects Wallet to Gemini for personal finance insights in the U.S. — Google AI Blog
  3. Anthropic’s IPO Is About Six Times Oversubscribed — Bloomberg AI
  4. Anthropic launches Claude Fable 5.2, topping AI index amid rivalry with GPT-6 Astra — DEV Community — AI
  5. Developers build shared tooling to manage Claude Code, Codex and Copilot usage and memory — DEV Community — AI
  6. Google launches Gemini 4 Hydrogen, a speed-focused AI model, alongside Decisions API and smart glasses — Google DeepMind Blog
  7. AWS releases AWS Emulator, a free tool that simulates 200+ services locally, saying AI agents wrote it and its team hasn't written or reviewed any of its code — Techmeme
  8. AI coding agents accelerate code writing, but verification and release remain bottlenecks — DEV Community — AI

Get the daily brief of stories like this at 6:30 every morning →